Dr. Gautier Decock
Managing Director of Seqens CRDO Business
Gautier Decock holds a Ph D in analytical chemistry from the University of Lille in France. After more than 10 years of experience within the pharma and cosmetic industry as Head of Analytic Laboratories, Gautier decided to join an analytical service provider as Managing Director of SGS Life Science Services in France. In 2012, Gautier joined Eurofins Pharma Quality Control as Managing Director, and was then appointed General Manager of Eurofins Pharmaceutical Product Testing in Belgium then Managing Director in Switzerland.
In 2014, Gautier was appointed General Manager of Eurofins IDMYK, after the acquisition of IDmyk, a leading laboratory specialized in the areas of detection, identification and molecular typing of microorganisms for the pharmaceutical industry. Gautier was then appointed Managing Director of Eurofins BioPharma Product Testing Nederland. Gautier joined Seqens in 2020 and today he has more than 25 years of experience in analytical science for Pharma, Biopharma, Medical Device and Cosmetic.
DAY 1: NOVEMBER 30th, 2023
SESSION: Nitrosamine Drug Substance -Related Impurities Management at SEQENS
◆ Risk Assessment Approach.
◆ Analytical Screening & Identification of NDSRIs.
◆ Toxicological Qualifications.
◆ Quantification of Ultra-Traces NDSRIs.
◆ Control Strategy.